¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå
Wearable Heart Monitoring Devices
»óǰÄÚµå : 1798303
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 375 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀåÀº 2030³â±îÁö 87¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 29¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 20.1%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 87¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ Àü±â ÆÞ½º ±â¹Ý µð¹ÙÀ̽º´Â CAGR 18.3%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 54¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±¤±â¼ú ±â¹Ý µð¹ÙÀ̽º ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 23.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 7¾ï 8,740¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 26.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀåÀº 2024³â¿¡ 7¾ï 8,740¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀ» 26.7%·Î, 2030³â±îÁö 20¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 16.2%¿Í 17.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 16.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â°¡ ¿À´Ã³¯ÀÇ °Ç°­ »ýŰ迡¼­ Á¡Á¡ ´õ Áß¿äÇØÁö´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ÀåÄ¡´Â Àü ¼¼°è¿¡¼­ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Áö¼ÓÀûÀÎ ½Ç½Ã°£ °Ç°­ ÃßÀûÀÇ Çʿ伺À¸·Î ÀÎÇØ Çö´ë ÀÇ·á¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ºü¸£°Ô ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. ½º¸¶Æ®¿öÄ¡, °¡½¿ ½ºÆ®·¦, ÆÐÄ¡, ¼¾¼­°¡ ºÎÂøµÈ ÀÇ·ù µîÀ» Æ÷ÇÔÇÑ ÀÌ·¯ÇÑ ÀåÄ¡µéÀº ÀÓ»ó ȯ°æ ¹Û¿¡¼­ ºñħ½ÀÀûÀ¸·Î ½É¹Ú¼ö, ¸®µë ºÒ±ÔÄ¢¼º ¹× ±âŸ ½ÉÀå ÁöÇ¥¸¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ ½É°¢ÇÑ ½ÉÀåÁúȯÀ» ¿¹¹æÇϱâ À§ÇÑ Á¶±â ¹ß°ßÀÇ °¡Ä¡¸¦ ÀνÄÇϰí ÀÖÀ¸¸ç, ±× Á߿伺ÀÌ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ºÎÁ¤¸ÆÀ̳ª ½É¹æ¼¼µ¿°ú °°Àº ¸¹Àº ½ÉÀåÁúȯÀº °£ÇæÀûÀ̾ Á¤±â°ËÁø¿¡¼­ ¹ß°ßµÇÁö ¾ÊÀ» ¼ö ÀÖÀ¸¹Ç·Î Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÌ Áß¿äÇÕ´Ï´Ù. ¿þ¾î·¯ºíÀº ÀÏ»ó »ýȰ, ¿îµ¿, ÈÞ½Ä, ¼ö¸é Áß ½ÉÀå ±â´ÉÀ» ÃßÀûÇÒ ¼ö ÀÖÀ¸¸ç, Àå±âÀûÀÎ ½ÉÀå °Ç°­ »óŸ¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÉÀåÁúȯÀÌ ¾Ë·ÁÁø ȯÀÚÀÇ °æ¿ì, ÀÌ·¯ÇÑ ÀåÄ¡´Â ¾ÈÀü¸Á ¿ªÇÒÀ» Çϸç, ÀÇ·á Á¶Ä¡°¡ ÇÊ¿äÇÑ ÀÌ»ó ¡Èĸ¦ ȯÀÚ¿Í Àǻ翡°Ô °æ°íÇÕ´Ï´Ù. ¿¹¹æÀÇÇп¡¼­ ¿þ¾î·¯ºí ¸ð´ÏÅÍ´Â ½Ä½À°ü, ¿îµ¿, ½ºÆ®·¹½º, ¼ö¸éÀÌ ½ÉÀåÀÇ ¼º´É¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸¿©ÁÜÀ¸·Î½á »ç¿ëÀÚ°¡ »ýȰ½À°üÀ» ¹Ù²Ü ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ÀÌ·¯ÇÑ ±ÇÇÑ ºÎ¿© ¼öÁØÀº ÇコÄɾ ´ëÇÑ Àû±ØÀûÀÎ Âü¿©¸¦ À¯µµÇϰí Á¶±â °³ÀÔ Àü·«À» ÃËÁøÇÕ´Ï´Ù. ½ÉÀ庴ÀÌ ¿©ÀüÈ÷ ¼¼°è »ç¸Á¿øÀÎ 1À§ÀÎ °¡¿îµ¥, ½ÉÀå ±â´ÉÀ» ÀÏ»óÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ´Â ±â´ÉÀº ½ÉÀå °Ç°­À» À¯ÁöÇÏ´Â ¹æ¹ýÀ» º¯È­½Ã۰í, ¹ÝÀÀÀû Ä¡·á¿¡¼­ ¿¹¹æÀû Ä¡·á·Î ÀüȯÇϰí ÀÖ½À´Ï´Ù.

¼¾¼­ ±â¼ú°ú Ä¿³ØÆ¼ºñƼÀÇ ±â¼ú Çõ½ÅÀº ÀåºñÀÇ ¼º´ÉÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

ÃÖ±Ù ¼¾¼­ ±â¼ú, ¹«¼± ¿¬°á ¹× µ¥ÀÌÅÍ ºÐ¼®ÀÇ ¹ßÀüÀ¸·Î ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ÀåÄ¡ÀÇ Á¤È®¼º, ½Å·Ú¼º ¹× ±â´É¼ºÀÌ Å©°Ô Çâ»óµÇ°í ÀÖ½À´Ï´Ù. Ãֽбâ±â´Â Æí¾ÈÇÔ°ú µðÀÚÀÎÀ» Èñ»ýÇÏÁö ¾Ê°í ÀÇ·á¿ë µ¥ÀÌÅ͸¦ Á¦°øÇÏ´Â °í±Þ ±¤ÇÐ ¼¾¼­¿Í ½ÉÀüµµ ±â´ÉÀ» °®Ãß°í ÀÖ½À´Ï´Ù. ºÎǰÀÇ ¼ÒÇüÈ­¸¦ ÅëÇØ ÀÌ·¯ÇÑ ±â¼úÀ» ÇÏ·ç Á¾ÀÏ Âø¿ëÇÒ ¼ö ÀÖ´Â ¼¼·ÃµÇ°í °¡º­¿î Çü½ÄÀ¸·Î ÅëÇÕÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Á¤±³ÇÑ ¸ð¼Ç ¾Ë°í¸®ÁòÀº ¿òÁ÷ÀÓ¿¡ ÀÇÇÑ ½ÅÈ£ °£¼·À» Á¦°ÅÇϱâ À§ÇØ »ç¿ëµÇ¸ç, ±× °á°ú °í°­µµ Ȱµ¿À̳ª ºÒ±ÔÄ¢ÇÑ ¿òÁ÷ÀÓ¿¡¼­µµ º¸´Ù Á¤È®ÇÑ ½É¹Ú¼ö ÃßÀûÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ƯÈ÷ ºí·çÅõ½º, ¿ÍÀÌÆÄÀÌ, ÈÞ´ëÆù ³×Æ®¿öÅ©¸¦ ÅëÇÑ ¿¬°á¼º Çâ»óÀ¸·Î ½º¸¶Æ®ÆùÀ̳ª Ŭ¶ó¿ìµå Ç÷§ÆûÀ¸·Î ¿øÈ°ÇÑ µ¥ÀÌÅÍ Àü¼ÛÀÌ °¡´ÉÇØÁ® ½Ç½Ã°£À¸·Î ÀúÀå, ºÐ¼®, ÀÇ·á Àü¹®°¡¿Í °øÀ¯°¡ °¡´ÉÇØÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ ±â´ÉÀ» ÅëÇØ ¿ø°Ý Áø´Ü, Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ, Àû½Ã¿¡ ÀÇ·á Á¶¾ðÀ» Á¦°øÇÔÀ¸·Î½á ´ë¸é Áø·áÀÇ Çʿ伺À» ¾ø¾Ù ¼ö ÀÖ½À´Ï´Ù. ÇöÀç ¸¹Àº ±â±âµéÀº ÀΰøÁö´ÉÀ» »ç¿ëÇÏ¿© µ¥ÀÌÅ͸¦ ÇØ¼®Çϰí, ÀáÀçÀûÀÎ ¹®Á¦¸¦ Ç¥½ÃÇϰí, ´ÙÀ½ ´Ü°è¸¦ Á¦¾ÈÇÏ´Â ÄÄÆÐ´Ï¾ð ¾Û°ú ¦À» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ±â±â¿¡´Â Ç÷Áß »ê¼ÒÆ÷È­µµ, È£Èí¼ö, ½ºÆ®·¹½º Áö¼ö µîÀÇ Ãß°¡ ÁöÇ¥µµ Æ÷ÇԵDZ⠽ÃÀÛÇØ ½ÉÇ÷°ü °Ç°­ »óŸ¦ º¸´Ù Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¹èÅ͸® È¿À²ÀÌ È¹±âÀûÀ¸·Î °³¼±µÇ¾î ÃæÀü °£°ÝÀ» ´Ã¸± ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ» ÅëÇØ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅÍ´Â ±× ¾î´À ¶§º¸´Ù È¿°úÀûÀ̰í, »ç¿ëÇϱ⠽¬¿ì¸ç, ÀÏ»ó »ýȰ¿¡ ´õ Àß ³ì¾Æµé ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

ÇÇÆ®´Ï½º, ÀÓ»ó, ¼ÒºñÀÚ À£´Ï½º ºÎ¹®¿¡¼­ÀÇ Ã¤Åà µ¿·ÂÀº ¹«¾ùÀΰ¡?

ÇÇÆ®´Ï½º ¾ÖÈ£°¡, ¸¸¼ºÁúȯ °ü¸® ȯÀÚ, ÀÇ·áÁø, °Ç°­°ü¸® ÇÁ·Î¹ÙÀÌ´õ, À£ºùÀ» Ãß±¸ÇÏ´Â ¼ÒºñÀÚ µî ´Ù¾çÇÑ »ç¿ëÀÚÃþ¿¡¼­ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±âÀÇ Ã¤ÅÃÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ÇÇÆ®´Ï½º ºÐ¾ß¿¡¼­´Â ¿îµ¿¼±¼ö¿Í ·¹Å©¸®¿¡ÀÌ¼Ç ¸ñÀûÀ¸·Î ¿îµ¿ÇÏ´Â »ç¶÷µéÀÌ ¿îµ¿ °­µµ¸¦ ÃÖÀûÈ­Çϰí, ȸº¹À» ÃßÀûÇϰí, °ú·Î¸¦ ÇÇÇϱâ À§ÇØ ½ÉÀå ¸ð´ÏÅ͸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ½É¹Ú¼ö º¯µ¿À» ÃøÁ¤ÇÏ´Â ±â±â´Â ƯÈ÷ ¿îµ¿°ú ÈÞ½ÄÀÇ ±ÕÇüÀ» ¸ÂÃß±â À§ÇØ ³ë·ÂÇÏ´Â »ç¶÷µé »çÀÌ¿¡¼­ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ÀÓ»ó ÇöÀå¿¡¼­´Â Àǻ簡 ½ÉÀåÁúȯ¿¡¼­ ȸº¹µÈ ȯÀÚ³ª ºÎÁ¤¸Æ Æò°¡¸¦ ¹Þ°í Àִ ȯÀÚ¿¡°Ô ¿þ¾î·¯ºí ¸ð´ÏÅ͸¦ ó¹æÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ±âÁ¸ÀÇ È¦ÅÍ ¸ð´ÏÅ͸¦ ´ëüÇÒ ¼ö ÀÖ´Â ºÎ´ã½º·´Áö ¾Ê°í ºñ¿ë È¿À²ÀûÀÎ ´ë¾ÈÀ» Á¦°øÇϸç, ´õ ±ä ½Ã°£ µ¿¾È ¸ð´ÏÅ͸µÀÌ °¡´ÉÇÏ°í ´õ Á¾ÇÕÀûÀÎ µ¥ÀÌÅ͸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ °Ç°­ ºÐ¾ß¿¡¼­´Â ÀÏ»óÀûÀÎ ½À°üÀÌ ½ÉÇ÷°ü °Ç°­¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡´ÂÁö ¾Ë±â À§ÇØ ¿þ¾î·¯ºíÀ» ÀÌ¿ëÇÏ´Â »ç¶÷µéÀÌ ´Ã°í ÀÖ½À´Ï´Ù. COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ ½ÉÀå ¹× È£Èí±â °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ º¸´Ù ±¤¹üÀ§ÇÑ È°·Â ¡ÈÄ ±â´ÉÀ» °®Ãá ¿þ¾î·¯ºí ¸ð´ÏÅÍ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ±â¾÷ À£´Ï½º ÇÁ·Î±×·¥ ¹× º¸Çè ÇÁ·Î¹ÙÀÌ´õµéµµ ¿¹¹æÀû Á¶Ä¡·Î ½ÉÀå ¸ð´ÏÅ͸µ ÀåÄ¡ »ç¿ëÀ» Àå·ÁÇϰí, Âü°¡Àڵ鿡°Ô ÇÒÀÎ ¹× Àμ¾Æ¼ºê¸¦ Á¦°øÇÕ´Ï´Ù. ¿ø°Ý Áø·á°¡ º¸ÆíÈ­µÊ¿¡ µû¶ó ÀÇ·á ½Ã½ºÅÛÀº ¿þ¾î·¯ºí ±â¼úÀ» ¿ø°ÝÀÇ·á Ç÷§Æû¿¡ ÅëÇÕÇÏ¿© °¡»ó ȯÀÚ Ä¡·á¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °¢ ºÐ¾ß¿¡¼­ÀÇ À¯ºñÄõÅͽºÈ­´Â °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í µðÁöÅзΠ¿¬°áµÈ ¼¼»ó¿¡¼­ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ ¹ü¿ë¼º°ú Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ½À» ÀÔÁõÇÕ´Ï´Ù.

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅÍ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÈ­ÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú Çõ½Å, Àα¸ µ¿Çâ, ÇコÄɾî Çõ½Å, ¼ÒºñÀÚ Çൿ º¯È­ µî ¿©·¯ °¡Áö ¼ö·Å ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ù°, Àü ¼¼°è¿¡¼­ ½ÉÇ÷°ü ÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÉÀåÁúȯÀÇ Á¶±â Áø´Ü°ú Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» ¿ëÀÌÇÏ°Ô ÇÏ´Â Åø¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µÑ°, ¸¹Àº ±¹°¡¿¡¼­ °í·ÉÈ­°¡ ÁøÇàµÇ¸é¼­ Àå±âÀûÀÎ ½ÉÀå ¸ð´ÏÅ͸µ ¹× ¿ø°Ý Ä¡·á ¿É¼ÇÀÇ ÇýÅÃÀ» ´©¸± ¼ö ÀÖ´Â ´ë±Ô¸ð »ç¿ëÀÚ ±â¹ÝÀÌ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. ¼Â°, °³ÀÎÈ­µÈ °Ç°­ µ¥ÀÌÅÍ¿Í À£´Ï½º¿¡ ´ëÇÑ Áö½ÄÀ» ¾ò°íÀÚ ÇÏ´Â ¼ÒºñÀÚ ¼ö¿ä´Â ½Ç½Ã°£À¸·Î ½Ç¿ëÀûÀÎ Çǵå¹éÀ» Á¦°øÇÏ´Â ¿þ¾î·¯ºí ±â±âÀÇ Àα⸦ ´õ¿í ºÎÃß±â°í ÀÖ½À´Ï´Ù. ³Ý°, ¼¾¼­ÀÇ ¼ÒÇüÈ­, ¹èÅ͸® ±â¼ú, ¹«¼±Åë½ÅÀÇ ±Þ¼ÓÇÑ ¹ßÀüÀ¸·Î ÀÏ»ó »ýȰ¿¡ ½±°Ô ³ì¾Æµé ¼ö ÀÖ´Â º¸´Ù Á¤È®ÇÏ°í Æí¾ÈÇÑ ±â±â°¡ ½ÇÇöµÇ°í ÀÖ½À´Ï´Ù. ´Ù¼¸Â°, ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ¸¸¼ºÁúȯ °ü¸® °­È­, º´¿ø ÀçÀÔ¿ø °¨¼Ò, ÀçÅà ġ·á Àü·«À» Áö¿øÇϱâ À§ÇØ ÀÌ·¯ÇÑ ±â¼úÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¿©¼¸Â°, °ø°ø ¹× ¹Î°£ º¸Çè»ç´Â ¿¹¹æÀû »ç¿ëÀ» Àå·ÁÇÏ°í »óȯ ¸ðµ¨À» Áö¿øÇÔÀ¸·Î½á ¿þ¾î·¯ºí ¸ð´ÏÅ͸µÀÇ ºñ¿ë Àý°¨ °¡´É¼ºÀ» ÀνÄÇϱ⠽ÃÀÛÇß½À´Ï´Ù. Àϰö°, µðÁöÅÐ Çコ ÀÎÇÁ¶ó¿Í ¸ð¹ÙÀÏ Çコ ¿ëµµÀÇ º¸±ÞÀ¸·Î ¿þ¾î·¯ºí µ¥ÀÌÅÍ¿¡ ½±°Ô Á¢±Ù, ÇØ¼®, °øÀ¯ÇÒ ¼ö ÀÖ´Â ¿øÈ°ÇÑ »ýŰ谡 ±¸ÃàµÇ°í ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î ±ÔÁ¦ ´ç±¹ÀÌ ´õ ¸¹Àº ¿þ¾î·¯ºí ±â±â¸¦ ÀÇ·á¿ëÀ¸·Î ½ÂÀÎÇϱ⠽ÃÀÛÇϸ鼭 ÀÓ»ó ÇöÀå¿¡¼­ÀÇ ½Å·Ú¼º°ú µµÀÔÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀεéÀÌ °áÇÕµÇ¾î ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº Çö´ë ÀÇ·á ¹× ÇコÄɾîÀÇ ÇÙ½ÉÀ¸·Î¼­ Áö¼ÓÀûÀÎ È®Àå°ú Çõ½ÅÀ» º¸ÀåÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

±â¼ú(Àü±â ÆÞ½º ±â¹Ý ±â±â, ±¤ÇÐ ±â¼ú ±â¹Ý ±â±â), ±â±â À¯Çü(Áø´Ü¡¤¸ð´ÏÅ͸µ ±â±â, Ä¡·á ±â±â), ¿ëµµ(½ºÆ÷Ã÷¡¤ÇÇÆ®´Ï½º ¿ëµµ, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¿ëµµ, ÀçÅà ÇコÄÉ¾î ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Wearable Heart Monitoring Devices Market to Reach US$8.7 Billion by 2030

The global market for Wearable Heart Monitoring Devices estimated at US$2.9 Billion in the year 2024, is expected to reach US$8.7 Billion by 2030, growing at a CAGR of 20.1% over the analysis period 2024-2030. Electric Pulse-based Devices, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the Optical Technology-based Devices segment is estimated at 23.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$787.4 Million While China is Forecast to Grow at 26.7% CAGR

The Wearable Heart Monitoring Devices market in the U.S. is estimated at US$787.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 26.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.2% and 17.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.7% CAGR.

Global Wearable Heart Monitoring Devices Market - Key Trends & Drivers Summarized

Why Are Wearable Heart Monitoring Devices Becoming Vital in Today’s Health Ecosystem?

Wearable heart monitoring devices are rapidly becoming essential components of modern healthcare, driven by the increasing global prevalence of cardiovascular diseases and the need for continuous, real-time health tracking. These devices, which include smartwatches, chest straps, patches, and sensor-equipped garments, allow for non-invasive monitoring of heart rate, rhythm irregularities, and other cardiac metrics outside clinical settings. Their importance has grown significantly as both patients and healthcare providers recognize the value of early detection in preventing serious cardiac events. Many heart conditions such as arrhythmias or atrial fibrillation can be intermittent and go undetected during routine check-ups, making continuous monitoring critical. Wearables enable users to track their cardiac function during everyday activities, exercise, rest, and even sleep, providing a comprehensive view of heart health over time. For patients with known heart conditions, these devices serve as a safety net, alerting them and their physicians to abnormalities that may require medical attention. In preventive care, wearable monitors help users make lifestyle changes by showing the impact of diet, exercise, stress, and sleep on heart performance. This level of empowerment encourages active participation in health management and fosters early intervention strategies. With heart disease remaining the leading cause of death globally, the ability to monitor cardiac function on a daily basis is transforming the way heart health is maintained, moving from reactive to proactive care.

How Are Innovations in Sensor Technology and Connectivity Enhancing Device Performance?

Recent advancements in sensor technology, wireless connectivity, and data analytics are significantly improving the accuracy, reliability, and functionality of wearable heart monitoring devices. Modern devices now feature advanced optical sensors and electrocardiogram capabilities that deliver medical-grade data without sacrificing comfort or design. The miniaturization of components has enabled these technologies to be embedded in sleek, lightweight formats suitable for all-day wear. Sophisticated motion algorithms are being used to eliminate signal interference caused by movement, resulting in more accurate heart rate tracking during high-intensity activities or irregular motion. Connectivity improvements, especially through Bluetooth, Wi-Fi, and cellular networks, allow for seamless data transmission to smartphones and cloud platforms, where it can be stored, analyzed, and shared with healthcare professionals in real time. These features enable remote diagnosis, ongoing supervision, and timely medical advice without the need for in-person appointments. Many devices are now paired with companion apps that use artificial intelligence to interpret data, flag potential issues, and suggest next steps. Wearable devices are also beginning to include additional metrics like blood oxygen saturation, respiratory rate, and stress indicators, creating a more holistic picture of cardiovascular health. Battery efficiency has improved dramatically, allowing for longer use between charges, which is especially important for devices intended for continuous monitoring. All these innovations are making wearable heart monitors more effective, more user-friendly, and more integrated into everyday life than ever before.

What Is Driving Adoption Across Fitness, Clinical, and Consumer Wellness Segments?

The adoption of wearable heart monitoring devices is accelerating across a wide range of user segments, including fitness enthusiasts, patients managing chronic conditions, healthcare providers, and wellness-focused consumers. In the fitness sector, athletes and recreational exercisers rely on heart monitors to optimize training intensity, track recovery, and avoid overexertion. Devices that measure heart rate variability are especially popular among those seeking to fine-tune performance and balance effort with rest. In clinical settings, doctors are prescribing wearable monitors for patients recovering from cardiac events or undergoing evaluation for arrhythmias. These devices offer a less intrusive and more cost-effective alternative to traditional Holter monitors and enable longer monitoring periods that capture more comprehensive data. In the consumer health space, people are increasingly turning to wearables for insights into how everyday habits affect their cardiovascular health. The COVID-19 pandemic heightened awareness of heart and respiratory health, prompting a surge in demand for wearable monitors with broader vital sign capabilities. Corporate wellness programs and insurance providers are also encouraging the use of heart monitoring devices as a preventive measure, offering discounts and incentives to participants. As remote care becomes more commonplace, healthcare systems are integrating wearable technology into telehealth platforms to enhance virtual patient care. This growing ubiquity across segments demonstrates the versatility and increasing necessity of wearable heart monitoring solutions in a health-conscious, digitally connected world.

What Are the Primary Drivers Accelerating Market Growth for Wearable Heart Monitors?

The growth in the wearable heart monitoring devices market is driven by multiple converging factors that span technological innovation, demographic trends, healthcare transformation, and changing consumer behavior. First, the rising global burden of cardiovascular diseases is increasing demand for tools that facilitate early diagnosis and continuous monitoring of heart conditions. Second, the aging population in many countries is creating a large user base that benefits from long-term cardiac surveillance and remote care options. Third, consumer demand for personalized health data and wellness insights is fueling the popularity of wearable devices that deliver real-time, actionable feedback. Fourth, rapid advancements in sensor miniaturization, battery technology, and wireless communication are enabling more accurate and comfortable devices that integrate easily into daily routines. Fifth, healthcare providers are adopting these technologies to enhance chronic disease management, reduce hospital readmissions, and support home-based care strategies. Sixth, public and private insurers are beginning to recognize the cost-saving potential of wearable monitoring by incentivizing preventive use and supporting reimbursement models. Seventh, the proliferation of digital health infrastructure and mobile health applications is creating seamless ecosystems where wearable data can be easily accessed, interpreted, and shared. Finally, regulatory agencies are beginning to approve more wearable devices for medical use, increasing credibility and adoption across clinical settings. These combined drivers are ensuring the continued expansion and innovation of the wearable heart monitoring devices market as a cornerstone of modern healthcare and wellness.

SCOPE OF STUDY:

The report analyzes the Wearable Heart Monitoring Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Electric Pulse-based Devices, Optical Technology-based Devices); Device Type (Diagnostic & Monitoring Devices, Therapeutic Devices); Application (Sports & Fitness Application, Remote Patient Monitoring Application, Home Healthcare Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â